These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17950908)

  • 1. Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms.
    Chu CF; Meador MG; Young CG; Strasser JE; Bourne N; Milligan GN
    J Reprod Immunol; 2008 Jun; 78(1):58-67. PubMed ID: 17950908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
    Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
    Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine.
    Halford WP; Püschel R; Gershburg E; Wilber A; Gershburg S; Rakowski B
    PLoS One; 2011 Mar; 6(3):e17748. PubMed ID: 21412438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.
    Awasthi S; Huang J; Shaw C; Friedman HM
    J Virol; 2014 Aug; 88(15):8421-32. PubMed ID: 24829358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.
    Hook LM; Cairns TM; Awasthi S; Brooks BD; Ditto NT; Eisenberg RJ; Cohen GH; Friedman HM
    PLoS Pathog; 2018 May; 14(5):e1007095. PubMed ID: 29791513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
    Tengvall S; O'Hagan D; Harandi AM
    Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2.
    Halford WP; Geltz J; Messer RJ; Hasenkrug KJ
    PLoS One; 2015; 10(12):e0145228. PubMed ID: 26670699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2.
    Parr EL; Parr MB
    J Virol; 1997 Nov; 71(11):8109-15. PubMed ID: 9343160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract.
    Milligan GN; Bernstein DI
    Virology; 1995 Jan; 206(1):234-41. PubMed ID: 7831778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, ΔgD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus.
    Ramsey NLM; Visciano M; Hunte R; Loh LN; Burn Aschner C; Jacobs WR; Herold BC
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection.
    Önnheim K; Ekblad M; Görander S; Bergström T; Liljeqvist JÅ
    Viruses; 2016 Apr; 8(4):110. PubMed ID: 27110813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract.
    Gallichan WS; Rosenthal KL
    Virology; 1996 Oct; 224(2):487-97. PubMed ID: 8874509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa.
    Milligan GN; Dudley-McClain KL; Chu CF; Young CG
    Virology; 2004 Jan; 318(2):507-15. PubMed ID: 14972519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor.
    Lin X; Lubinski JM; Friedman HM
    J Virol; 2004 Mar; 78(5):2562-71. PubMed ID: 14963159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone.
    Awasthi S; Lubinski JM; Shaw CE; Barrett SM; Cai M; Wang F; Betts M; Kingsley S; Distefano DJ; Balliet JW; Flynn JA; Casimiro DR; Bryan JT; Friedman HM
    J Virol; 2011 Oct; 85(20):10472-86. PubMed ID: 21813597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
    Tengvall S; Harandi AM
    J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease.
    Görander S; Harandi AM; Lindqvist M; Bergström T; Liljeqvist JÅ
    J Virol; 2012 Jul; 86(14):7544-53. PubMed ID: 22553328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection.
    Lebratti T; Lim YS; Cofie A; Andhey P; Jiang X; Scott J; Fabbrizi MR; Ozantürk AN; Pham C; Clemens R; Artyomov M; Dinauer M; Shin H
    Elife; 2021 May; 10():. PubMed ID: 34047696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections.
    Whaley KJ; Zeitlin L; Barratt RA; Hoen TE; Cone RA
    J Infect Dis; 1994 Mar; 169(3):647-9. PubMed ID: 8158042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection.
    Johnson AJ; Nelson MH; Bird MD; Chu CF; Milligan GN
    J Reprod Immunol; 2010 Jan; 84(1):8-15. PubMed ID: 19942296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.